BIOECLIPSE
Live / Registered — Registered (as of 04 May 2021)
What this means for you
Registered since 04 May 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 04 May 2027, and its filing window is open now).
Record
- Serial number
- 87398361
- Registration number
- 6341819
- Mark type
- Word mark
- Filed
- 04 Apr 2017
- Published for opposition
- 08 Aug 2017
- Registered
- 04 May 2021
- Next maintenance filing
- §8 declaration of use, due by 04 May 2027 (grace period to 04 Nov 2027)
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Immunotherapies for the treatment of cancer; pharmaceuticals for the treatment of cancer
Owner
- BIOECLIPSE THERAPEUTICS, INC., MOUNTAIN VIEW, CA, US
- BIOECLIPSE THERAPEUTICS, INC., MOUNTAIN VIEW, CA, US
- ConcentRx, Inc., Mountain View, CA, US
- ConcentRx, Inc., Milpitas, CA, US
Prosecution history
- 04 May 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 30 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Oct 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Oct 2020 — NON-FINAL ACTION E-MAILED
- 09 Oct 2020 — SU - NON-FINAL ACTION - WRITTEN